Payden & Rygel
- SEC CIK
- 0000919219
- Latest filing
- Jul 31, 2026
AMGN holding history
Amgen Inc in every 13F filed by Payden & Rygel, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AMGN overviewAll 13F holders of AMGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,800
- Value
- $652.0K
- % of portfolio
- 0.1%
- Quarters held
- 18
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,800 | $652.0K | 0.1% | +1,800 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −5,300−100.0% | Sold out | Holders |
| Q2 2025 | 5,300 | $1.48M | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 5,300 | $1.65M | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 5,300 | $1.38M | 0.1% | −30,100−85.0% | Reduced | Holders |
| Q3 2024 | 35,400 | $11.4M | 0.9% | +200+0.6% | Added | Holders |
| Q2 2024 | 35,200 | $11.0M | 0.9% | −22,700−39.2% | Reduced | Holders |
| Q1 2024 | 57,900 | $16.5M | 1.1% | +52,600+992.5% | Added | Holders |
| Q4 2023 | 5,300 | $1.53M | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 5,300 | $1.42M | 0.1% | +5,300 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −70,540−100.0% | Sold out | Holders |
| Q1 2023 | 70,540 | $17.1M | 1.0% | +69,440+6,312.7% | Added | Holders |
| Q4 2022 | 1,100 | $289.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 1,100 | $248.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 1,100 | $268.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 1,100 | $266.0K | <0.1% | −101,040−98.9% | Reduced | Holders |
| Q4 2021 | 102,140 | $23.0M | 1.1% | −33,700−24.8% | Reduced | Holders |
| Q3 2021 | 135,840 | $28.9M | 1.5% | +3,800+2.9% | Added | Holders |
| Q2 2021 | 132,040 | $32.2M | 1.5% | −2,300−1.7% | Reduced | Holders |
| Q1 2021 | 134,340 | $33.4M | 1.6% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.